Differential requirement for c-Jun N-terminal kinase 1 in lung inflammation and host defense
Jos Van der Velden1, Yvonne M W Janssen-Heininger, Sivanarayna Mandalapu
1Department of Pathology, University of Vermont, Burlington, Vermont, United States of America.
Abstract:
The c-Jun N-terminal kinase (JNK) - 1 pathway has been implicated in the cellular response to stress in many tissues and models. JNK1 is known to play a role in a variety of signaling cascades, including those involved in lung disease pathogenesis. Recently, a role for JNK1 signaling in immune cell function has emerged. The goal of the present study was to determine the role of JNK1 in host defense against both bacterial and viral pneumonia, as well as the impact of JNK1 signaling on IL-17 mediated immunity. Wild type (WT) and JNK1 -/- mice were challenged with Escherichia coli, Staphylococcus aureus, or Influenza A. In addition, WT and JNK1 -/- mice and epithelial cells were stimulated with IL-17A. The impact of JNK1 deletion on pathogen clearance, inflammation, and histopathology was assessed. JNK1 was required for clearance of E. coli, inflammatory cell recruitment, and cytokine production. Interestingly, JNK1 deletion had only a small impact on the host response to S. aureus. JNK1 -/- mice had decreased Influenza A burden in viral pneumonia, yet displayed worsened morbidity. Finally, JNK1 was required for IL-17A mediated induction of inflammatory cytokines and antimicrobial peptides both in epithelial cells and the lung. These data identify JNK1 as an important signaling molecule in host defense and demonstrate a pathogen specific role in disease. Manipulation of the JNK1 pathway may represent a novel therapeutic target in pneumonia.
Insights
The c-Jun N-terminal kinase 1 (JNK1) pathway is crucial for clearing bacterial pneumonia and producing immune signals. JNK1 plays a pathogen-specific role in host defense against lung infections.
Area of Science:
- Immunology
- Molecular Biology
- Pathology
Background:
- The c-Jun N-terminal kinase 1 (JNK1) pathway is involved in cellular stress responses and lung disease pathogenesis.
- Emerging evidence highlights JNK1 signaling's role in immune cell function.
Purpose of the Study:
- To investigate the role of JNK1 in host defense against bacterial and viral pneumonia.
- To determine JNK1's impact on IL-17 mediated immunity.
Main Methods:
- Comparison of wild-type (WT) and JNK1 knockout (JNK1-/-) mice challenged with Escherichia coli, Staphylococcus aureus, or Influenza A.
- Stimulation of WT and JNK1-/- mice and epithelial cells with IL-17A.
- Assessment of pathogen clearance, inflammation, and histopathology.
Main Results:
- JNK1 deficiency impaired clearance of E. coli, inflammatory cell recruitment, and cytokine production.
- JNK1 deletion had a minimal effect on the host response to S. aureus.
- JNK1-/- mice showed reduced Influenza A viral burden but increased morbidity.
- JNK1 was essential for IL-17A-induced inflammatory cytokine and antimicrobial peptide production in lung epithelial cells.
Conclusions:
- JNK1 is critical for host defense, exhibiting pathogen-specific roles in pneumonia.
- JNK1 is required for IL-17A-mediated immune responses in the lung.
- Targeting the JNK1 pathway could offer a novel therapeutic strategy for pneumonia.
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
cAMP-dependent Protein Kinase Pathways
TGF - β Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

